January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Entos Pharmaceuticals
Entos Pharmaceuticals' Fusogenix™ Proteo-Lipid Vehicle™ (PLV™) platform, enables precision, re-dosable non-viral delivery of all nucleic acids payloads (DNA, RNA, or combinations), ushering in the new era of genetic medicine.